On May 6, 2020, from 12:15 pm - 1:15 pm Eastern Time, the U.S. Food and Drug Administration (FDA) will host a virtual Town Hall for clinical laboratories and commercial manufacturers that are developing or have developed diagnostic tests for SARS-CoV-2.
The purpose of this Town Hall is to help answer technical questions about the development and validation of tests for SARS-CoV-2.
Slides and transcripts for previous Town Halls from this series are also available.